Full List Of Stories
Director dealings: Biopharma Credit director buys after IPO
Biopharma Credit director Colin Bond has snapped up £100,000 of shares in the newly listed investment trust, which is focused on generating sustainable income distributions from exposure to the debt assets issued by the life sciences industry.
Allergy Therapeutics starts strong ahead of big second half
Allergy Therapeutics reported strong underlying revenue growth in the first half, boosted by an increased market share for its flagship Pollinex Quattro allergy treatment and one analyst feels the company's run of bad luck might be ending.
Ofcom demands changes to BBC broadcasting output
Ofcom, which on Monday will become the first independent regulator of the BBC, has proposed a wide-ranging set of new rules for the public broadcaster, including imposing minimum quotas on television and radio output of news, arts and sports and greater spending on original programming.
'No flights' between UK and Europe from 2019 is possibility, warns Ryanair
There could be no flights between the UK and Europe in the immediate aftermath of Britain exiting the European Union, according to one airline.
Pernod hikes prices for Absolut vodka, Beefeater gin after pound slump
Pernod Ricard, owner of popular alcohol brands including Absolut vodka, Jameson whiskey and Malibu rum, has hiked UK prices on its spirits and wines in order to counterbalance the effect of the pound's slump since the Brexit referendum and rising inflation.
Saga sags as results disappoint despite 18% dividend hike
Over-50's insurer and tour operator Saga proposed an 18% dividend hike after delivering a solid year of profits growth.
No end in sight for iron ore supply glut, BHP warns
BHP Billiton iron ore chief Edgar Basto has warned that the supply of low-cost seaborne iron ore is expected to grow faster than demand, but assured that company is well-positioned to continue to grow value and shareholder returns.